Anaphylactic Shock due to Oral Levofloxacin After Cataract Surgery: A Case Report
DOI:
https://doi.org/10.38035/dhps.v4i2.3871Keywords:
Anaphylactic shock, Levofloxacin, FluoroquinoloneAbstract
Background: Levofloxacin is a fluoroquinolone antibiotic that is generally safe to use, but can cause severe hypersensitivity reactions such as anaphylactic shock in rare cases. Objectives: This study are use to report a case of anaphylactic shock following oral levofloxacin administration after cataract surgery and to describe its clinical manifestations and management. Methods: This study used a case study design with retrospective data collection from the patient's medical records. Data were analyzed descriptively and compared with literature findings related to fluoroquinolone hypersensitivity reactions. Results: A 60-year-old man developed a generalized erythematous rash, recurrent vomiting, diarrhea, shortness of breath, severe hypotension, and tachycardia within 15 minutes of taking oral levofloxacin following cataract surgery. Physical examination revealed widespread urticaria accompanied by a blood pressure of 70/50 mmHg, and laboratory tests revealed leukocytosis, elevated creatinine, and hypokalemia. The patient showed clinical improvement after fluid resuscitation, administration of the vasopressor norepinephrine, intravenous corticosteroids, antihistamines, and other supportive therapy, and was ultimately discharged in stable condition. Conclusions: Anaphylactic shock due to oral levofloxacin is a rare but life-threatening event that can occur even in the absence of a prior history of allergy. Early recognition and prompt and appropriate management are crucial to prevent fatal clinical outcomes.
References
1.Fernandez, T. D. et al. Hypersensitivity to fluoroquinolones : The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone. Medicine (Baltimore). 23, (2016).
2. Gelincik, A., Brockow, K., Çelik, G. E., Demir, S. & Doña, I. Diagnosis of Quinolone Hypersensitivity : An EAACI Position Paper. 2988–3011 (2025) doi:10.1111/all.70037.
3. Zhao, Y. et al. Drug ‑ induced anaphylaxis in China : a 10 year retrospective analysis of the Beijing Pharmacovigilance Database. Int. J. Clin. Pharm. 40, 1349–1358 (2018).
4. Bahekar, S. E. & More, P. D. Case Report A Rare Case Report of Levofloxacin ‑ and Solifenacin ‑ Induced Acute Anaphylactic Reaction in an Elderly Patient. 101–102 (2019)
5. Lee, J. et al. A Case of Levofloxacin-Induced Anaphylaxis With Elevated Serum Tryptase Levels. Allergy. Asthma Immunol. Res. 5, 113–115 (2013).
6. Ghoshal, A., Damani, A., Salins, N., Deodhar, J. & Muckaden, M. A. Acute Palliative Care Case Series Management of Levofloxacin Induced Anaphylaxis and Acute Delirium in a Palliative Care Setting. 21, 76–78 (2015).
7. Sheth, H. J., Sood, S. V, Patel, R. P. & Malhotra, S. D. A case report on angioedema induced by levofloxacin : an unexpected occurrence. Int. J. Basic Clin. Pharmacol. 6, 2749–2751 (2017).
8. Wu, T. S., Liu, Y. H., Wu, Z. F. & Tse, J. CASE REPORT Anaphylactic Shock Induced by Higher Doses But Not Lower Doses of Cisatracurium. 45, 166–168 (2025).
9. Boostani, M., Bar-ilan, E. & Hidvégi, B. Anaphylaxis with Elevated Procalcitonin Mimicking Sepsis : A Literature Review and Report of Two Cases. (2025).
10. Pouessel, G., Tacquard, C., Kase, L., Michel, P. & Guillaume, M. Anaphylaxis mortality in the perioperative setting : Epidemiology , elicitors , risk factors and knowledge gaps. 11–20 (2024)
11. Mali, S. Anaphylaxis during the perioperative period. Anesth. Essays Res. 6, (2012).
12. Dewachter, P. & Savic, L. Perioperative anaphylaxis : pathophysiology , clinical presentation and management. BJA Educ. 19, 313–320 (2019).
13. Espa, S., Gomez, A. V. M., Belver, M. T. & Alvarez, N. C. Perioperative anaphylactic reactions : Review and procedure protocol in paediatrics. Allergol. Immunopathol. (Madr). 43, (2015).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Henny Tan, William, Suparto

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright :
Authors who publish their manuscripts in this journal agree to the following conditions:
- Copyright in each article belongs to the author.
- The author acknowledges that the DHPS has the right to be the first to publish under a Creative Commons Attribution 4.0 International license (Attribution 4.0 International CC BY 4.0).
- Authors can submit articles separately, arrange the non-exclusive distribution of manuscripts that have been published in this journal to other versions (for example, sent to the author's institutional repository, publication in a book, etc.), by acknowledging that the manuscript has been published for the first time at DHPS.






















